No Data
ZHITONG AH Statistics | July 22
AH Statistics | July 22
Trump: Impose 100% tariffs on imported generic drugs starting August 2028
President Trump stated that generic drug manufacturers will have two years to shift their production to the United States, or else face a 100% import tariff starting in August 2028, with the rate increasing to 200% in August 2029. Trump indicated that this measure aims to bring generic drug manufacturing back to the U.S. and penalize companies that choose not to build facilities and equipment within the specified timeframe. He added that the White House’s tariff plan for branded pharmaceuticals will remain unchanged; this plan seeks to impose tariffs of up to 100% on certain imported drugs, though it will provide certain exemptions for pharmaceutical manufacturers.
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year
AI-driven drug development exacerbating the 'monkey shortage'?
Second-quarter report of Ge Lan's China Europe Healthcare Hybrid Fund: Junshi Biosciences (688180.SH) newly entered the top ten holdings; innovative drugs and their industrial chain remain the primary investment focus.
On July 21, China Europe Fund Management disclosed the second-quarter 2026 report for the China Europe Healthcare Hybrid Securities Investment Fund, co-managed by Ge Lan and Zhao Lei.
ZHITONG AH Statistics | July 21
AH Statistics | July 21